MELINDA HILL: Open Payments
NPI 1467594770 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 43 payments from 21 companies in 2025. Trend: 2023 $30 · 2024 $174 · 2025 $970
Food & beverage: $877Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $172 |
| Daiichi Sankyo Inc. | 4 | $103 |
| Incyte Corporation | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| ABBVIE INC. | 4 | $64 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Eisai Inc. | 3 | $47 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 2 | $33 |
Products named: Enhertu, LUPRON DEPOT, ERLEADA, OJJAARA, SCEMBLIX, DATROWAY, Lenvima, ZYNLONTA.
Industry payments across MO — which companies pay providers there.
